301 related articles for article (PubMed ID: 947533)
1. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ
Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy of Hodgkin's disease in children.
Kolygin BA
Cancer; 1976 Oct; 38(4):1494-7. PubMed ID: 991072
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
Diggs CH; Wiernik PH; Levi JA; Kvols LK
Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
Gibbs GE; Peterson BA; Kennedy BJ; Vosika G; Bloomfield CD
Arch Intern Med; 1981 Jun; 141(7):897-900. PubMed ID: 7235809
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy of advanced Hodgkin's disease. A review.
Goldsmith MA; Carter SK
Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
[No Abstract] [Full Text] [Related]
7. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Krikorian JG; Portlock CS; Rosenberg SA
Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
[TBL] [Abstract][Full Text] [Related]
10. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
11. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
[TBL] [Abstract][Full Text] [Related]
12. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
[TBL] [Abstract][Full Text] [Related]
13. The treatment of advanced hodgkin's disease.
Straus DJ; Lee BJ; Koziner B; Nisce LZ; Young CW; Clarkson BD
Blut; 1981 Aug; 43(2):119-24. PubMed ID: 6167303
[TBL] [Abstract][Full Text] [Related]
14. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
Case DC; Young CW; Lee BJ
Cancer; 1977 Apr; 39(4):1382-6. PubMed ID: 66972
[TBL] [Abstract][Full Text] [Related]
16. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
Zelechowska JA; Madej G; Piemkowska F
Nowotwory; 1976; 26(3):163-70. PubMed ID: 980801
[No Abstract] [Full Text] [Related]
17. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
18. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
[No Abstract] [Full Text] [Related]
19. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
[No Abstract] [Full Text] [Related]
20. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
